FEATURE ARTICLES
In October , FDA issued a draft guidance titled Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities: Guidance for Industry, which describes how the FDA is operating their remote evaluations program, the logistics of its implementation, and what they expect of industry. The public comment period ends December 26.
- Your 6 Priority Areas For A Successful 2024
- Emerging Trends & Technologies In Anti-Counterfeit Pharmaceutical Packaging
- Outsourcing And Phase-Appropriate GMP For Clinical Manufacturing Needs
- A Brief Introduction To Environmental Monitoring For Startups
- Leveraging An Application Managed Services (AMS) Provider For Pharma/Biotech Serialization Systems
- Your Local Affiliates Want More From Your Global Regulatory Information Management
- Enteric Gel Capsules Market Flourishes As Demand For Advanced Drug Delivery Surges
PHARMA ONLINE WHITE PAPERS
-
![Freeze thaw cold chain GettyImages-1292998528]( "Impact Of Freeze-Drying Process And Lyoprotectants On Nanoparticle Stability")
Impact Of Freeze-Drying Process And Lyoprotectants On Nanoparticle StabilityRead highlights from a recent webinar describing the challenges of freeze-drying nanoparticles and how a group has designed and evaluated solutions to lyophilizing LNPs.
-
Selecting The Locations Of Particle Monitoring For The Fill-Finish Process4/28/2022
Learn about the monitoring of particles (viable and non-viable) during the fill-finish process of drug manufacturing and considerations for the location of airborne particle monitors.
-
Monkeypox Vaccine: What To Expect9/21/2022
We answer your most pressing questions about how the monkeypox vaccine works and how it’s manufactured.
-
The Business Value Of Connectivity For Product Inspection Equipment3/16/2022
Realize the value of connectivity, and more specifically, the value of information provided by checkweighing, metal detection, vision inspection, and x-ray inspection.
-
Bench To Bedside: A Scalable End-To-End Solution For AAV Production8/30/2022
How to efficiently translate bench-scale processes to commercial GMP manufacturing to produce viral vectors at the scale needed to meet dosage requirements.
-
Modern Manufacturing: The Investment in Digitization Costs Less Than Falling Behind2/1/2022
By adopting digital solutions today, manufacturers can capitalize on the opportunities of modern manufacturing solutions and realize their full potential.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Illustrating A Successful Small Biotech-CDMO Relationship
- Take Advantage Of Single-Use Technologies For Microbial Processes
- Study Of Single Use Device Media Dehydration And Biological Recovery Efficiency
- ACQUITY And XBridge Premier Protein SEC 250 Å Columns: A New Benchmark In Inert SEC Column Design
- Determining Thermal Stability Of Antibodies With A Nano DSC
NEWSLETTER ARCHIVE
- 12.06.23 -- The Future Of Lipid Nanoparticles In Developing Cell And Gene Therapy
- 12.05.23 -- Meet Pharma's Future By Embracing GMP Manufacturing
- 12.05.23 -- Leveraging An Application Managed Services (AMS) Provider For Pharma/Biotech Serialization Systems
- 12.01.23 -- Your Local Affiliates Want More From Your Global Regulatory Information Management
- 11.30.23 -- Advancing Process Understanding Through Simulation And Digital Transformation
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
On the surface, the future laboratory looks like an end to paper notebooks, adding solar panels on the roof, and lots of automation. But those are just the trimmings for a greater transformation as laboratories modernize. Check out the latest e-book from Pharmaceutical Online.
More Content Collections
